carvedilol has been researched along with Non-alcoholic Fatty Liver Disease in 2 studies
Non-alcoholic Fatty Liver Disease: Fatty liver finding without excessive ALCOHOL CONSUMPTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol is a widely used beta-adrenoreceptor antagonist for multiple cardiovascular indications; however, it may induce cholestasis in patients, but the mechanism for this effect is unclear." | 1.91 | Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis. ( Alaei Faradonbeh, F; Bayer, RL; Dohnalkova, E; Dusek, J; Faistova, H; Hirsova, P; Hroch, M; Hyspler, R; Kucera, O; Lastuvkova, H; Micuda, S; Mokry, J; Nova, Z; Pavek, P; Schreiberova, J; Stefela, A, 2023) |
| "They revealed that both improved NAFLD especially nicorandil treated proved by the reduction of liver enzymes (AST, ALT), the fatty infiltration determined histologically and biochemically (decrease liver triglycerides)." | 1.51 | Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats. ( Abdallah, H; Abdel Maksoud, OM; Bastawy, N; Ibrahim, W; Morsi, H; Rashed, LA; Soliman, GF, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lastuvkova, H | 1 |
| Nova, Z | 1 |
| Hroch, M | 1 |
| Alaei Faradonbeh, F | 1 |
| Schreiberova, J | 1 |
| Mokry, J | 1 |
| Faistova, H | 1 |
| Stefela, A | 1 |
| Dusek, J | 1 |
| Kucera, O | 1 |
| Hyspler, R | 1 |
| Dohnalkova, E | 1 |
| Bayer, RL | 1 |
| Hirsova, P | 1 |
| Pavek, P | 1 |
| Micuda, S | 1 |
| Soliman, GF | 1 |
| Rashed, LA | 1 |
| Morsi, H | 1 |
| Ibrahim, W | 1 |
| Abdallah, H | 1 |
| Bastawy, N | 1 |
| Abdel Maksoud, OM | 1 |
2 other studies available for carvedilol and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Carvedilol impairs bile acid homeostasis in mice: implication for nonalcoholic steatohepatitis.
Topics: Animals; Bile Acids and Salts; Carvedilol; Homeostasis; Humans; Liver; Male; Membrane Transport Prot | 2023 |
Interrelation of liver vascularity to non-alcoholic fatty liver through a comparative study of the vasodilator effect of carvedilol or nicorandil in rats.
Topics: Adrenergic beta-Antagonists; Animals; Carvedilol; Liver; Male; Nicorandil; Non-alcoholic Fatty Liver | 2019 |